Although AML is distinct from MPN, we analyzed USP5 in AML due to (1) shared molecular features in bone marrow dysfunction, and (2) limited availability of MPN patient databases with transcriptomic data. This evidence concerns the gene USP5 and myeloproliferative neoplasm.